LONDON, UK / ACCESSWIRE / April 20, 2018 / Active-Investors has a free review on Simulations Plus, Inc. (NASDAQ: SLP) following the Company's announcement that it will begin trading ex-dividend on April 24, 2018. To capture the dividend payout, investors must purchase the stock a day prior to the ex-dividend date that is by latest at the end of the trading session on April 23, 2018. Active-Investors has initiated due-diligence on this dividend stock. Register with us for more free research including the one on SLP:
If your portfolio includes dividend stocks, you have come to the right place for timely information. All you need to do is sign up for your free membership at:
On April 09, 2018, Simulations Plus' Board of Directors declared a cash dividend of $0.06 per share of the Company's common stock payable on May 02, 2018, to shareholders of record as of April 25, 2018.
Simulations Plus' indicated dividend represents a yield of 1.38%, which is considerably higher than the average dividend yield of 1.01% for the Technology sector.
Simulations Plus has a dividend payout ratio of 60%, which indicates that the Company spends approximately $0.60 for dividend distribution out of every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.
According to analysts' estimates, Simulations Plus is forecasted to report earnings of $0.50 for the next year, which is more than double compared to the Company's annualized dividend of $0.24 per share.
As of February 28, 2018, Simulations Plus' cash and cash equivalent totaled $6.92 million compared to $6.22 million as on August 31, 2017. The Company's total current assets as on February 28, 2018, were $15.33 million, while its total current liabilities were $5.52 million. The Company's strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain the dividend distribution for a long period.
On April 09, 2018, Simulations Plus reported financial results for its second quarter fiscal year 2018 ended February 28, 2018. The Company's revenues surged 28.9% to $7.4 million for Q2 FY18 compared to $5.7 million in Q2 FY17
For Q2 FY18, Simulations Plus' gross profit was $5.2 million, up 26.2% compared to $4.2 million in Q2 FY17. The Company's reported quarter income from operations was $2.4 million, up 34.7% compared to $1.8 million in the prior year's same quarter.
Simulations Plus reported net income of $3.5 million, or $0.19 per share, for Q2 FY18 compared to $1.2 million, or $0.07 per share, in Q2 FY17. Excluding the tax adjustments, the Company's income would have been $2.0 million, or $0.11 per share, for the reported quarter.
About Simulations Plus, Inc.
Simulations Plus is a premier developer of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting services. The Company is a global leader focused on improving the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical, biotechnology, and chemical agents. Simulations Plus' software is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, chemical, and consumer goods companies and regulatory agencies worldwide.
Stock Performance Snapshot
April 19, 2018 - At Thursday's closing bell, Simulations Plus' stock climbed 1.41%, ending the trading session at $17.95.
Volume traded for the day: 55.55 thousand shares, which was above the 3-month average volume of 54.82 thousand shares.
Stock performance in the last month – up 13.25%; previous three-month period – up 13.07%; past twelve-month period – up 58.85%; and year-to-date – up 11.49%
After yesterday's close, Simulations Plus' market cap was at $313.77 million.
Price to Earnings (P/E) ratio was at 46.03.
The stock has a dividend yield of 1.34%.
The stock is part of the Technology sector, categorized under the Business Software & Services industry.
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visithttp://active-investors.com/legal-disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.